Sec Form 13G Filing - SYNERGY LIFE SCIENCE PARTNERS L P filing for Inspire Medical Systems Inc. (INSP) - 2020-02-05

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b),

(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b)

(Amendment No. 1)*

 

 

Inspire Medical Systems, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

457730109

(CUSIP Number)

December 31, 2019

(Date of Event Which Requires Filing of This Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

Rule 13d-1(c)

☒ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP NO. 457730109    13 G   

 

  1    

  NAMES OF REPORTING PERSONS.

 

  Synergy Life Science Partners, LP

  2    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)  ☐        (b)  ☒ (1)

 

  3    

  SEC USE ONLY

 

  4    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Delaware

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    5     

  SOLE VOTING POWER

 

  0 shares

  6     

  SHARED VOTING POWER

 

  0 shares

  7     

  SOLE DISPOSITIVE POWER

 

  0 shares

  8     

  SHARED DISPOSITIVE POWER

 

  0 shares

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  0 shares

10    

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

  ☐

11    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  0.0%

12    

  TYPE OF REPORTING PERSON*

 

  PN

 

(1)

This Schedule 13G is filed by Synergy Life Science Partners, LP, a Delaware limited partnership (“SLSP”), Synergy Venture Partners, LLC, a Delaware limited liability company (“SVP”), Richard S. Stack (“Stack”) and William N. Starling, Jr. (“Starling” and together with SLSP, SVP, and Stack, collectively, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G. The information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2019.


CUSIP NO. 457730109    13 G   

 

  1    

  NAMES OF REPORTING PERSONS.

 

  Synergy Venture Partners, LLC

  2    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)  ☐        (b)  ☒ (1)

 

  3    

  SEC USE ONLY

 

  4    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Delaware

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    5     

  SOLE VOTING POWER

 

  0 shares

  6     

  SHARED VOTING POWER

 

  0 shares

  7     

  SOLE DISPOSITIVE POWER

 

  0 shares

  8     

  SHARED DISPOSITIVE POWER

 

  0 shares

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  0 shares

10    

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

  ☐

11    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  0.0%

12    

  TYPE OF REPORTING PERSON*

 

  OO

 

(1)

This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G. The information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2019.


CUSIP NO. 457730109    13 G   

 

  1    

  NAMES OF REPORTING PERSONS.

 

  Richard S. Stack

  2    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)  ☐        (b)  ☒ (1)

 

  3    

  SEC USE ONLY

 

  4    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States of America

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    5     

  SOLE VOTING POWER

 

  35,459 shares

  6     

  SHARED VOTING POWER

 

  0 shares

  7     

  SOLE DISPOSITIVE POWER

 

  35,459 shares

  8     

  SHARED DISPOSITIVE POWER

 

  0 shares

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  35,459 shares

10    

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

  ☐

11    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  0.0%

12    

  TYPE OF REPORTING PERSON*

 

  IN

 

(1)

This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G. The information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2019.


CUSIP NO. 457730109    13 G   

 

  1    

  NAMES OF REPORTING PERSONS.

 

  William N. Starling, Jr.

  2    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)  ☐        (b)  ☒ (1)

 

  3    

  SEC USE ONLY

 

  4    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States of America

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    5     

  SOLE VOTING POWER

 

  22,874 shares

  6     

  SHARED VOTING POWER

 

  0 shares

  7     

  SOLE DISPOSITIVE POWER

 

  22,874 shares

  8     

  SHARED DISPOSITIVE POWER

 

  0 shares

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  22,874 shares

10    

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

  ☐

11    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  0.0%

12    

  TYPE OF REPORTING PERSON*

 

  IN

 

(1)

This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G. The information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2019.


Introductory Note: This Statement on Schedule 13G (this “Statement”) is filed on behalf of the Reporting Persons, in respect of shares of Common Stock, par value $0.001 per share (“Common Stock”), of Inspire Medical Systems, Inc. (the “Issuer”).

 

Item 1

 

(a)    Name of Issuer:    Inspire Medical Systems, Inc.
   Address of Issuer’s Principal Executive Offices:    5500 Wayzata Blvd., Suite 1600
      Golden Valley, MN 55416

 

Item 2

 

(a)    Name of Person(s) Filing:
  

Synergy Life Science Partners, LP (“SLSP”)

Synergy Venture Partners, LLC (“SVP”)

Richard S. Stack (“Stack”)

William N. Starling, Jr. (“Starling”)

 

(b)    Address of Principal Business Office:    c/o Synergy Life Science Partners
      4020 Stirrup Creek Drive, Suite 115
      Durham, NC 27703

 

(c)    Citizenship:           
   Entities:    SLSP      -   

 Delaware

      SVP      -   

 Delaware

   Individuals:    Stack      -   

 United States of America

      Starling      -   

 United States of America

(d)    Title of Class of Securities:   

 Common Stock

(e)    CUSIP Number:   

 457730109

 

Item 3

Not applicable.


Item 4

Ownership.

The following information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2019:

 

Filing Person

   Shares of
Common
Stock
     Sole
Voting
Power
     Shared
Voting
Power
     Sole
Dispositive
Power
     Shared
Dispositive
Power
     Beneficial
Ownership
     Percentage
of Class
 

Synergy Life Science Partners, LP

     0        0        0        0        0        0        0.0

Synergy Venture Partners, LLC

     0        0        0        0        0        0        0.0

William N. Starling, Jr.

     22,874        22,874        0        22,874        0        22,874        0.0

Richard S. Stack

     35,459        35,459        0        35,459        0        35,459        0.0

 

Item 5

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof, the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following:  ☒

 

Item 6

Ownership of More Than Five Percent on Behalf of Another Person.

Not applicable.

 

Item 7

Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.

Not applicable.

 

Item 8

Identification and Classification of Members of the Group.

Not applicable.

 

Item 9

Notice of Dissolution of Group.

Not applicable.

 

Item 10

Certification.

Not applicable.


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 5, 2020

 

SYNERGY LIFE SCIENCE PARTNERS, LP
By: Synergy Venture Partners, LLC
Its: General Partner
By:  

/s/ William N. Starling, Jr.

  Name: William N. Starling, Jr.
  Title: Manager
SYNERGY VENTURE PARTNERS, LLC
By:  

/s/ William N. Starling, Jr.

  Name: William N. Starling, Jr.
  Title: Manager

/s/ William N. Starling, Jr.

William N. Starling, Jr.

/s/ Richard S. Stack

Richard S. Stack

Exhibit(s):

A - Joint Filing Statement